Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001231919-08-000085

Options or other derivatives

  • Chief Financial Officer acquired 2,750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lamadrid David Chief Financial Officer 2008-06-25 Grant or award · Employee Stock Option (Right to Buy) +2,750,000 2,750,000 D: show line 1 in the form
Loading xslF345X03/edgar.xml…